JPRN-UMIN000020997已完成2 期
Phase II study to evaluate the efficacy of intra-bone cord blood transplantation for adult patients with hematological malignancy - Phase II study to evaluate the efficacy of intra-bone cord blood transplantation for adult patients with hematological malignancy
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine0 个研究点目标入组 65 人开始时间: 2016年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Positive for HBs-Ag, HCV-Ab, or HIV-Ab 2. In pregnancy or breast-feeding 3. Double cancer 4. Uncontrolled psychiatric disorder 5. Uncontrolled infectious disease 6. Allergy to drugs for transplant preconditioning or GVHD prophylaxis 7. Re-transplantation within 6 months from the preceding transplantation 8. Doctor's decision
研究者
相似试验
进行中（未招募）
不适用
A pilot phase II study to assess the efficacy of Brentuximab Vedotin administered sequentally with ABVD chemotherapy in patients with untreated Hodgkin LymphomaEUCTR2012-002012-46-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA
尚未招募
不适用
Probiotics for patients with cancersCTRI/2021/03/032021Christian Medical College Vellore
进行中（未招募）
1 期
A phase II randomised study evaluating the biological and clinical effects of the combination of palbociclib with letrozole as neoadjuvant therapy in post-menopausal women with ER+ primary breast cancer.ER positive, HER2 negative early invasive breast cancerMedDRA version: 18.1Level: PTClassification code 10057654Term: Breast cancer femaleSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-000887-16-GBThe Royal Marsden NHS Foundation Trust306
招募中
2 期
A Phase 2 clinical study to assess efficacy of Induction ipilimumab/nivolumab to spare the Bladder in urothelial bladder cancer (IndiBlade)Urothelial carcinoma of the bladder and bladder cancer10038364NL-OMON52087Antoni van Leeuwenhoek Ziekenhuis50
招募中
2 期
A phase 2 study to investigate the effectiveness of combination immunotherapy followed by chemoradiation of the tumor in patients with bladder cancer (Indi-blade).2024-512211-41-00Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting50